Ethiopia confirms first deadly Marburg virus outbreak as Africa faces mounting public-health crises
Ethiopia has confirmed its first outbreak of Marburg virus disease (MVD), adding another layer of strain to a continent already confronting multiple public-health emergencies. The announcement, made on November 15 by the Africa Centers for Disease Control and Prevention (Africa CDC), follows laboratory verification of the virus in Ethiopia’s southern region, marking a troubling milestone in the country’s health landscape.
Authorities issued an initial alert on November 12 after reports of a suspected viral haemorrhagic fever emerged from the town of Jinka, a remote area near Ethiopia’s borders with Kenya and South Sudan. The location raises concern, not only because of its limited health infrastructure, but also due to its proximity to major regional transit points that could facilitate cross-border spread.
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus confirmed on X (formerly Twitter) that at least nine infections have been identified. Although Ethiopia’s Health Ministry has not yet verified any fatalities, Russia’s public health agency, Rospotrebnadzor, citing several media sources, stated that six people may have died-including two healthcare workers who were actively treating infected patients. If confirmed, these deaths would underscore the virulence of the outbreak as well as the inherent risks faced by frontline medical personnel.
Local health authorities have initiated emergency response mechanisms in an effort to contain the outbreak before it escalates into a major health crisis. Field teams have been deployed to the affected areas, surveillance activities have been intensified, and strict infection prevention and control protocols have been reinforced across health facilities. Public awareness campaigns are now being rolled out to educate communities about symptoms, transmission risks, and preventative measures.
Africa CDC, in a statement, emphasized its commitment to supporting Ethiopia’s containment efforts: “Africa CDC will continue to work closely with the Government of Ethiopia and partners to ensure a rapid, coordinated and effective response.” The agency’s involvement is critical, particularly because MVD requires strict isolation procedures and swift contact tracing to halt transmission.
The emergence of Marburg virus in Ethiopia comes at a time when the African continent is confronting an unprecedented strain on its public-health systems. Earlier this year, Tanzania suffered its own Marburg outbreak, resulting in ten deaths. While that epidemic was successfully contained through rapid intervention, it heightened awareness of the virus’s capacity to spread quickly and lethally.
Compounding the challenge is Africa’s worst cholera outbreak in 25 years. With more than 300,000 confirmed and suspected cases and over 7,000 deaths recorded across the continent in 2025, cholera has further eroded health-care resources, stretched emergency response teams, and consumed budgets that might otherwise have been allocated to combating emerging threats like MVD.
Against this backdrop, Ethiopia’s detection of Marburg poses a serious risk. Resources diverted to this outbreak may weaken efforts to control other ongoing epidemics, particularly cholera and measles, which continue to affect vulnerable populations in several regions. Moreover, the ongoing conflict and displacement in parts of Ethiopia complicate surveillance and treatment efforts, as health teams may struggle to reach communities in remote or insecure areas.
The potential for regional spread has not gone unnoticed. Russian authorities have already announced heightened sanitary checks at border crossings, citing concerns about increased movement between East African countries. Rospotrebnadzor also reported that a Russian-developed Marburg vaccine has completed preclinical trials and is now prepared for clinical testing-a development that, if successful, could provide an invaluable tool for future outbreaks.
The situation underscores the interconnected nature of modern health security. Although Marburg virus outbreaks are relatively rare, they are notoriously deadly. The disease belongs to the same family of viruses as Ebola and can cause severe haemorrhagic fever with a fatality rate that has reached 88% in past outbreaks. Symptoms often begin abruptly, with fever, chills, nausea, vomiting, sore throat, and abdominal pain. In severe cases, patients experience profound internal and external bleeding, shock, organ failure, and death within days.
Transmission occurs through direct contact with infected bodily fluids, contaminated materials, or exposure to fruit bats-believed to be the natural reservoir of the virus. Healthcare workers face especially high risk without proper protective equipment, as evidenced by the suspected deaths of two Ethiopian medical personnel.
Marburg virus was first identified in 1967 during simultaneous outbreaks in Germany and Serbia, linked to imported African green monkeys used for research. Since then, sporadic outbreaks have occurred in Uganda, Angola, Kenya, and the Democratic Republic of Congo, often with devastating consequences for local populations and healthcare systems.
One of the deadliest incidents occurred in Angola in 2005, where more than 300 people died-many of them children. The outbreak exposed severe gaps in surveillance, diagnostic capacity, and public communication. Since then, African health authorities, supported by international partners, have significantly improved their ability to respond to viral haemorrhagic fevers. Nonetheless, the rapid appearance of Marburg in new regions highlights the need for sustained investment in early warning systems, laboratory networks, and community-based education programs.
Ethiopia now faces the difficult task of mobilizing a coordinated response while ensuring the virus does not gain a foothold in communities lacking adequate health services. The government will need to accelerate testing, expand isolation capacity, and trace contacts with precision-all while preserving public trust, combating misinformation, and preventing panic.
Given the country’s population size and regional influence, the stakes are high. A rapid containment could reinforce Ethiopia’s public-health resilience and provide a valuable case study for managing viral haemorrhagic fevers. Conversely, any delay or misstep could allow the virus to spread and intensify an already fragile health environment.
As Africa navigates this period of overlapping health emergencies, the Marburg outbreak in Ethiopia is a stark reminder of the continent’s vulnerability to emerging infectious diseases-and the urgent need for global solidarity, scientific innovation, and strengthened health systems capable of withstanding such threats.
Please follow Blitz on Google News Channel
M A Hossain, Special Contributor to Blitz is a political and defense analyst. He regularly writes for local and international newspapers.
